These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 8189338)

  • 1. Psychological profiles distinguishing litigating and nonlitigating pain patients: subtle, and not so subtle.
    Dush DM; Simons LE; Platt M; Nation PC; Ayres SY
    J Pers Assess; 1994 Apr; 62(2):299-313. PubMed ID: 8189338
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Use of biographical and case history data in the assessment of malingering during examination for disability.
    Lanyon RI; Almer ER; Curran PJ
    Bull Am Acad Psychiatry Law; 1993; 21(4):495-503. PubMed ID: 8054679
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Classification accuracy of MMPI-2 validity scales in the detection of pain-related malingering: a known-groups study.
    Bianchini KJ; Etherton JL; Greve KW; Heinly MT; Meyers JE
    Assessment; 2008 Dec; 15(4):435-49. PubMed ID: 18539782
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Detecting malingering in traumatic brain injury and chronic pain with an abbreviated version of the Meyers Index for the MMPI-2.
    Aguerrevere LE; Greve KW; Bianchini KJ; Meyers JE
    Arch Clin Neuropsychol; 2008; 23(7-8):831-8. PubMed ID: 18715751
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Utility of the Deceptive-Subtle items in the detection of malingering.
    Bagby RM; Nicholson R; Buis T
    J Pers Assess; 1998 Jun; 70(3):405-15. PubMed ID: 9841263
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identifying psychological contributions to chronic pain complaints with the MMPI-2: the role of the K scale.
    McGrath RE; Sweeney M; O'Malley WB; Carlton TK
    J Pers Assess; 1998 Jun; 70(3):448-59. PubMed ID: 9760738
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Subtle-obvious scales of the MMPI: indicators of profile validity in a psychiatric population.
    Brems C; Johnson ME
    J Pers Assess; 1991 Jun; 56(3):536-44. PubMed ID: 1865310
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Relative practical utility of the Minnesota Multiphasic Personality Inventory-2 Restructured Clinical Scales versus the Clinical Scales in a chronic pain patient sample.
    McCord DM; Drerup LC
    J Clin Exp Neuropsychol; 2011 Jan; 33(1):140-6. PubMed ID: 20665319
    [TBL] [Abstract][Full Text] [Related]  

  • 9. MMPI subtle-obvious scales and malingering: clinical versus simulated scores.
    Lees-Haley PR; Fox DD
    Psychol Rep; 1990 Jun; 66(3 Pt 1):907-11. PubMed ID: 2377710
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Utility of the MMPI-2-RF (Restructured Form) validity scales in detecting malingering in a criminal forensic setting: a known-groups design.
    Sellbom M; Toomey JA; Wygant DB; Kucharski LT; Duncan S
    Psychol Assess; 2010 Mar; 22(1):22-31. PubMed ID: 20230148
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Feigning schizophrenic disorders on the MMPI-2: detection of coached simulators.
    Rogers R; Bagby RM; Chakraborty D
    J Pers Assess; 1993 Apr; 60(2):215-26. PubMed ID: 8473961
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Utility of the MMPI-2-RF in detecting non-credible somatic complaints.
    Sellbom M; Wygant D; Bagby M
    Psychiatry Res; 2012 May; 197(3):295-301. PubMed ID: 22405634
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Relationships between physical findings (GPE-78) and psychological profiles (MMPI-2) in patients with long-lasting musculoskeletal pain.
    Kvåle A; Ellertsen B; Skouen JS
    Nord J Psychiatry; 2001; 55(3):177-84. PubMed ID: 11827612
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Impact of simulating borderline personality disorder on the MMPI-2: a costs-benefits model employing base rates.
    Sivec HJ; Hilsenroth MJ; Lynn SJ
    J Pers Assess; 1995 Apr; 64(2):295-311. PubMed ID: 7722855
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Faking the MMPI-2: utility of the Subtle-Obvious scales.
    Brems C; Harris K
    J Clin Psychol; 1996 Sep; 52(5):525-33. PubMed ID: 8877687
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Can psychosis be malingered on the Rorschach? An empirical study.
    Ganellen RJ; Wasyliw OE; Haywood TW; Grossman LS
    J Pers Assess; 1996 Feb; 66(1):65-80. PubMed ID: 8576836
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Incremental validity of the MMPI-2-RF over-reporting scales and RBS in assessing the veracity of memory complaints.
    Gervais RO; Ben-Porath YS; Wygant DB; Sellbom M
    Arch Clin Neuropsychol; 2010 Jun; 25(4):274-84. PubMed ID: 20335183
    [TBL] [Abstract][Full Text] [Related]  

  • 18. MMPI results: a comparison of trauma victims, psychogenic pain, and patients with organic disease.
    Chaney HS; Williams SG; Cohn CK; Vincent KR
    J Clin Psychol; 1984 Nov; 40(6):1450-4. PubMed ID: 6511963
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Psychometric perspectives on detection of malingering of pain: use of the Minnesota Multiphasic Personality Inventory-2.
    Arbisi PA; Butcher JN
    Clin J Pain; 2004; 20(6):383-91. PubMed ID: 15502681
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Reliability of the MMPI-2 Subtle and Obvious scales with psychiatric inpatients.
    Boone D
    J Pers Assess; 1994 Apr; 62(2):346-51. PubMed ID: 8189342
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.